藏格礦業(000408.SZ):2021年度淨利升523.60%至14.27億元
格隆匯3月10日丨藏格礦業(000408.SZ)披露2021年年度報吿,報吿期內,公司實現營業收入36.23億元,同比增長90.31%;歸屬於上市公司股東的淨利潤14.27億元,同比增長523.60%;歸屬於上市公司股東的扣除非經常性損益的淨利潤13.58億元,同比增長599.04%;經營活動現金淨流入20.35億元,而上年同期為淨流出1.74億元;基本每股收益0.73元。
報吿期內,公司主營業務穩步發展,以氯化鉀、碳酸鋰產品為重心,以巨龍銅業投資為輔助,圍繞控成本、提質量、穩產量、擴品類、拓渠道等主要目標推進工作,不斷夯實核心競爭力,推動盈利能力進一步提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.